Evidence map›Paper›PMID 30941888›Full record

ArticleJournal of cellular and molecular medicine2019

p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer.

Xiao-Yu Yan, Xin-Ru Zhong, Si-Hang Yu, Li-Chao Zhang, Ya-Nan Liu, Yong Zhang, Lian-Kun Sun, Jing Su

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  10. Review
  11. Role of autophagy and its regulation by noncoding RNAs in ovarian cancer.Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xiao-Yu YanDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Xin-Ru ZhongDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Si-Hang YuDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Li-Chao ZhangDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Ya-Nan LiuDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Yong ZhangDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Lian-Kun SunDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.
Jing SuDepartment of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, P.R. China.ORCID 0000-0001-7636-2946
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence suggests that p62/SQSTM1 functions as a signalling centre in cancer. However, the role of p62 in tumour development depends on the interacting factors it recruits and its precise regulatory mechanism remains unclear. In this study, we investigated the pro-death signalling recruitment of p62 with the goal of improving anti-tumour drug effects in ovarian cancer treatment. We found that p62 with Caspase 8 high expression is correlated with longer survival time compared with cases of low Caspase 8 expression in ovarian cancer. In vivo experiments suggested that insoluble p62 and ubiquitinated protein accumulation induced by autophagy impairment promoted the activation of Caspase 8 and increased cell sensitivity to cisplatin. Furthermore, p62 functional domain UBA and LIR mutants regulated autophagic flux and attenuated Caspase 8 activation, which indicates that autophagic degradation is involved in p62-mediated activation of Caspase 8 in ovarian cancer cells. Collectively, our study demonstrates that p62 promotes Caspase 8 activation through autophagy flux blockage with cisplatin treatment. We have provided evidence that autophagy induction followed by its blockade increases cell sensitivity to chemotherapy which is dependent on p62-Caspase 8 mediated apoptosis signalling. p62 exhibits pro-death functions through its interaction with Caspase 8. p62 and Caspase 8 may become novel prognostic biomarkers and oncotargets for ovarian cancer treatment.

Indexed as

AgedApoptosisAutophagyBiomarkers, TumorCaspase 8Cell Line, TumorCell SurvivalCisplatinDisease ProgressionFemaleHumansOvarian NeoplasmsRNA-Binding ProteinsSequestosome-1 ProteinSignal TransductionBiomarkers, TumorCASP8 protein, humanCaspase 8CisplatinP62 protein, humanRNA-Binding ProteinsSequestosome-1 ProteinapoptosisautophagyCaspase 8ovarian cancerp62

Identifiers

PMID30941888
PMCPMC6533521
OpenAlexW2926299965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.